Carol Wiggins, MD
Allergy · Atlanta, GANPI 1952339756
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations.
Across 218 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$563
- AstraZeneca$504
- CSL Behring$412
- Novartis$392
- GSK$386
- Takeda Pharmaceuticals U.S.A., Inc.$375
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,830100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 21 | $563 |
| AstraZeneca | 27 | $504 |
| CSL Behring | 18 | $412 |
| Novartis | 18 | $392 |
| GSK | 19 | $386 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $375 |
| Pfizer | 12 | $294 |
| Regeneron Healthcare Solutions, Inc. | 12 | $275 |
| Grifols USA, LLC | 12 | $236 |
| Biocryst US Sales Co., LLC | 10 | $211 |
| Pharming Healthcare, Inc. | 9 | $193 |
| Kaleo, Inc. | 10 | $169 |
| Octapharma USA, Inc. | 3 | $152 |
| Genentech USA, Inc. | 7 | $131 |
| Optinose US, Inc. | 5 | $103 |
| Amgen | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Boehringer Ingelheim | 2 | $40 |
| Blueprint Medicines Corporation | 2 | $40 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $24 |
| ADMA Biomanufacturing LLC | 1 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $23 |
| Alk-abello, Inc | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $19 |
| Biocryst Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
How this compares
Too few allergy providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 35 | $132,032 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 106 | $105,181 |
| Dupixent SyringeDupilumab | 24 | $89,808 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 24 | $56,072 |
| Breo ElliptaFluticasone/Vilanterol | 82 | $53,707 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $4,475 |
| Epinephrine | 17 | $2,894 |
| Triamcinolone Acetonide | 20 | $2,430 |
| Azelastine Hcl | 82 | $2,002 |
| Wixela InhubFluticasone Propion/Salmeterol | 23 | $1,907 |
| Montelukast Sodium | 173 | $1,819 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $1,803 |
| Fluticasone Propionate | 65 | $1,295 |
| Ipratropium Bromide | 21 | $843 |
| Levocetirizine Dihydrochloride | 17 | $367 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $386 | $158,888188 claims |
| CSL BehringPrivigen | $412 | $56,07224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Georgiaon file to place this against a meaningful peer group, so we don't.
Other allergy in Atlanta
- Amy HirshAtlanta$14K
- Theodore LeeAtlanta$11K
- Umbreen LodiAtlanta$47
- Thomas ChackoAlpharetta$63K
- Donnie DunaganAugusta$19K
- Tricia LeeDecatur$13K
- Anu MongiaCartersville$8K
- Tesneem ChaudharyAugusta$6K
- John HalwigAustell$5K
- Jaya TherattilAugusta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.